Effect of metformin on the expression of non-coding long-term RNA in diabetic patients.
Phase 2
- Conditions
- Diabetes mellitus type II in people New case.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20190303042903N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Has a fasting blood glucose level of 126 mg / dl
Exclusion Criteria
consumer metformin or any other hypoglycemic drug and any other drug like statin, antihypertensive, anti-inflammatory drug, and an ACE inhibitor.
A group of patients with cardiovascular disease and inflammatory diseases (such as lupus, rheumatoid arthritis, etc.)
A group of patients with a variety of cancers
A group of type 2 of diabetes
Group of people with hyperlipidemia and hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method